<?xml-stylesheet type="text/xsl" href="https://emersonexchange365.com/cfs-file/__key/system/syndication/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Continuous Manufacturing for Solid Dose Form&amp;#160;Pharmaceuticals</title><link>/community-hubs/deltav-community-connect/b/ops-weblog/posts/continuous-manufacturing-for-solid-dose-form-160-pharmaceuticals</link><description>Emerson’s Jonathan Lustri explores the trend towards continuous manufacturing for sold dose pharmaceuticals and the technologies and practices that make this possible. This past year I have become aware of a very big change that is coming to the pharmaceutical</description><dc:language>en-US</dc:language><generator>Telligent Community 13</generator></channel></rss>